Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19. COVID‐19 should be considered as a new triggering factor for autoimmune disorder...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021-10, Vol.9 (10), p.e04931-n/a
Main Authors: Shahidi Dadras, Mohammad, Rakhshan, Azadeh, Ahmadzadeh, Arman, Hosseini, Seyed Ali, Diab, Reem, Safari Giv, Toktam, Abdollahimajd, Fahimeh
Format: Article
Language:English
Subjects:
Antibodies
Autoimmune diseases
Biopsy
Cardiomyopathy
Cardiovascular disease
Case Report
Case reports
Collagen
Coronaviruses
COVID-19
Cytokines
Dermatology
dermatomyositis
Dyspnea
Edema
Erythema
Fever
Infections
Lupus
lupus erythematosus
Medical imaging
myositis
Pathogenesis
Patients
Pneumonia
Severe acute respiratory syndrome coronavirus 2
trigger
Vein & artery diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19. COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.4931